Hydroxychloroquine linked to higher risk of death in virus patients — Study

* Reveals risk of death 34% higher in patients who received Hydroxychloroquine

Web Editor | ConsumerConnect

A latest observational study of nearly 100,000 novel Coronavirus (COVID-19) patients, who received antimalarial drugs, including Hydroxychloroquine, has found that the drug is not as effective after all.

Agency report reveal that the study on the medication, which the United States President Donald Trump once flaunted as a solution to  fatal Coronavirus,  revealed that  the patients on whom the drug was applied had  an increased risk of death or cardiac issue.

The findings, published in medical journal, ‘The Lancet’, surveyed 96,000 Coronavirus patients across six continents of the world, report said.

It is regarded the biggest analysis yet of the use of antimalarial drugs to treat COVID-19.

The report showed that the risk of death was 34% higher in patients who received Hydroxychloroquine.

They also had a 137% higher risk of developing heart arrhythmia.

The risks rose higher for patients who took Hydroxychloroquine with an antibiotic:45% risk of death and 411% risk of arrhythmia.

Although The Lancet findings emerged only from an analysis of medical records and not from a controlled study, the size of the analysis offers scientists a basis to conclude that the drug can cause more harm than good if used to treat Coronavirus, experts opined.

There is little evidence yet that Hydroxychloroquine or Chloroquine is effective in the treatment of Coronavirus.

In Nigeria, for instance, the Presidential Task Force (PTF) on COVID 19 warned Nigerians against resort to the use of Hydroxychloroquine in treating Coronavirus.

Mr. Boss Mustapha, Secretary to the Government of the Federation (SGF) and Chairman of the PTF, declared in Abuja, FCT, that the drug had not been certified for use.

Mustapha disclosed to journalists at the PTF briefing in Abuja that reports reaching the Task Force from its surveillance system indicated that Nigerians had been purchasing Hydroxychloroquine in large quantities to treat the virus.

He stated: “We wish to reiterate that this drug has not been certified for use in treating COVID-19 in Nigeria by the relevant health and pharmaceutical authorities.

“Self-medication of any kind is fraught with the danger of increasing risks of avoidable casualties. We, therefore, strongly warn against self-medication.

“If you are sick, please seek medical advice and if you are confirmed positive, kindly self-isolate in an approved facility, the COVID-19 is highly infectious and dangerous.

Kindly Share This Story